{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:33:19Z","timestamp":1777433599960,"version":"3.51.4"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jsbmb.2019.105548","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T11:52:40Z","timestamp":1575287560000},"page":"105548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor"],"prefix":"10.1016","volume":"199","author":[{"given":"Nicole L.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne R.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmaeil","family":"Ebrahimie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa E.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne D.","family":"Tilley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2019.105548_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrc.2016.116","article-title":"Deciphering the divergent roles of progestogens in breast cancer","volume":"17","author":"Carroll","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0010","doi-asserted-by":"crossref","first-page":"T227","DOI":"10.1530\/ERC-16-0427","article-title":"Pushing estrogen receptor around in breast cancer","volume":"23","author":"Lim","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF01805865","article-title":"Oral high-dose medroxyprogesterone acetate (MAP) in treatment of advanced breast cancer. A preliminary report of clinical and experimental studies","volume":"1","author":"Izuo","year":"1981","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01803566","article-title":"Current status of high dose progestin treatment in advanced breast cancer","volume":"3","author":"Mattsson","year":"1983","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/1097-0142(19860701)58:1<7::AID-CNCR2820580103>3.0.CO;2-#","article-title":"Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer","volume":"58","author":"van Veelen","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1159\/000227233","article-title":"Treatment with tamoxifen and progestins for metastatic breast cancer in postmenopausal women: a quantitative review of published randomized clinical trials","volume":"50","author":"Parazzini","year":"1993","journal-title":"Oncology"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(99)00109-4","article-title":"Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells","volume":"154","author":"Bentel","year":"1999","journal-title":"Mol.Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0040","first-page":"5084","article-title":"Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells","volume":"48","author":"Sutherland","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2011.09.019","article-title":"Multiple nuclear receptor signaling pathways mediate the actions of synthetic progestins in target cells","volume":"357","author":"Moore","year":"2012","journal-title":"Mol.Cell Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0050","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.1995.13.7.1572","article-title":"Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression","volume":"13","author":"Birrell","year":"1995","journal-title":"J.Clin.Oncol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0055","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1158\/0008-5472.CAN-04-3077","article-title":"Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate","volume":"65","author":"Buchanan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1530\/ERC-12-0065","article-title":"An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity","volume":"19","author":"Moore","year":"2012","journal-title":"Endocr.Relat Cancer."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10549-011-1394-5","article-title":"Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells","volume":"131","author":"Courtin","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0070","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1016\/j.febslet.2005.08.084","article-title":"Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene","volume":"579","author":"Gizard","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0075","doi-asserted-by":"crossref","first-page":"43091","DOI":"10.1074\/jbc.M111.295865","article-title":"Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1\/DUSP1)","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0080","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1038\/sj.onc.1207601","article-title":"Progesterone prevents radiation-induced apoptosis in breast cancer cells","volume":"23","author":"Vares","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0085","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0960-0760(95)00005-K","article-title":"Androgens induce divergent proliferative responses in human breast cancer cell lines","volume":"52","author":"Birrell","year":"1995","journal-title":"J.Steroid Biochem.Mol.Biol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0090","first-page":"2422","article-title":"Direct inhibition of growth and antagonism of insulin action by glucocorticoids in human breast cancer cells in culture","volume":"39","author":"Osborne","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0095","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0006-291X(00)90001-9","article-title":"Expression of c-erbB-4\/HER4 is regulated in T47D breast carcinoma cells by retinoids and vitamin D3","volume":"258","author":"Offterdinger","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF01806528","article-title":"Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells","volume":"13","author":"Poulin","year":"1989","journal-title":"Breast Cancer Res.Treat."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF01806369","article-title":"Multiple actions of synthetic\u2019 progestins\u2019 on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids","volume":"17","author":"Poulin","year":"1991","journal-title":"Breast Cancer Res.Treat."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0110","doi-asserted-by":"crossref","first-page":"15180","DOI":"10.1073\/pnas.93.26.15180","article-title":"Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy","volume":"93","author":"Lee","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02106576","article-title":"Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin","volume":"13","author":"Poulin","year":"1989","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0120","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0092-8674(82)90218-5","article-title":"Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance","volume":"28","author":"Horwitz","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0125","doi-asserted-by":"crossref","first-page":"R1036","DOI":"10.1186\/bcr1340","article-title":"The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells","volume":"7","author":"Ghatge","year":"2005","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0130","first-page":"3352","article-title":"Establishment and characterization of three new continuous cell lines derived from human breast carcinomas","volume":"38","author":"Engel","year":"1978","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0135","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1093\/bioinformatics\/bth349","article-title":"Java Treeview--extensible visualization of microarray data","volume":"20","author":"Saldanha","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0140","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/bioinformatics\/bth078","article-title":"Open source clustering software","volume":"20","author":"de Hoon","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0145","series-title":"Venny. An Interactive Tool for Comparing Lists With Venn\u2019s Diagrams","author":"Oliveros","year":"2015"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0150","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0155","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/bioinformatics\/btg290","article-title":"Pathway studio--the analysis and navigation of molecular networks","volume":"19","author":"Nikitin","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0160","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/bioinformatics\/btg207","article-title":"MedScan, a natural language processing engine for MEDLINE abstracts","volume":"19","author":"Novichkova","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jviromet.2006.07.024","article-title":"Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors","volume":"138","author":"Reed","year":"2006","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0170","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1210\/endo-122-4-1532","article-title":"Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin","volume":"122","author":"Nardulli","year":"1988","journal-title":"Endocrinology."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0175","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1073\/pnas.97.3.1032","article-title":"Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome","volume":"97","author":"Lange","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0180","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0021-9258(18)48380-9","article-title":"Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones","volume":"267","author":"Kemppainen","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0185","first-page":"208","article-title":"Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability","volume":"9","author":"Zhou","year":"1995","journal-title":"Mol.Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0190","doi-asserted-by":"crossref","first-page":"42714","DOI":"10.1074\/jbc.M106033200","article-title":"Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids","volume":"276","author":"Wallace","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0195","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1210\/endo-109-6-1975","article-title":"Regulation of glucocorticoid receptors by glucocorticoids in cultured HeLa S3 cells","volume":"109","author":"Cidlowski","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0200","first-page":"2434","article-title":"Steroid receptor analyses of nine human breast cancer cell lines","volume":"38","author":"Horwitz","year":"1978","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0205","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","article-title":"Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception","volume":"76","author":"Africander","year":"2011","journal-title":"Steroids."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0210","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jsbmb.2014.05.007","article-title":"A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)","volume":"143","author":"Africander","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0215","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature14583","article-title":"Progesterone receptor modulates ERalpha action in breast cancer","volume":"523","author":"Mohammed","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0220","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrc3518","article-title":"Progesterone signalling in breast cancer: a neglected hormone coming into the limelight","volume":"13","author":"Brisken","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0225","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1158\/0008-5472.CAN-16-3541","article-title":"Breast Cancer suppression by progesterone receptors is mediated by their modulation of estrogen receptors and RNA polymerase III","volume":"77","author":"Finlay-Schultz","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0235","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women\u2019s Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0240","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0245","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1158\/1055-9965.EPI-10-0162","article-title":"Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California teachers Study","volume":"19","author":"Saxena","year":"2010","journal-title":"Cancer Epidemiol.Biomarkers Prev."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0250","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"JAMA."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0255","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ijc.24738","article-title":"A case-control study on hormone therapy as a risk factor for breast cancer in Finland: intrauterine system carries a risk as well","volume":"126","author":"Lyytinen","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0260","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamaoncol.2015.0494","article-title":"Breast Cancer After use of estrogen plus progestin and estrogen alone: analyses of data from 2 women\u2019s health initiative randomized clinical trials","volume":"1","author":"Chlebowski","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0265","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10549-014-2934-6","article-title":"Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort","volume":"145","author":"Fournier","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0270","first-page":"347","article-title":"Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro","volume":"9","author":"Goyette","year":"2017","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature09387","article-title":"Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer","volume":"468","author":"Schramek","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0280","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1096\/fj.06-7518com","article-title":"Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer","volume":"21","author":"Birrell","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078016","article-title":"Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France","volume":"8","author":"Cordina-Duverger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0290","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/09513590701382104","article-title":"Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase","volume":"23","author":"Espie","year":"2007","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2005.07.001","article-title":"Synthetic progestins used in HRT have different glucocorticoid agonist properties","volume":"242","author":"Koubovec","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0305","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","article-title":"Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile","volume":"73","author":"Sasagawa","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0310","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.jmb.2016.06.020","article-title":"Progesterone receptor signaling mechanisms","volume":"428","author":"Grimm","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0315","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.steroids.2010.09.006","article-title":"Membrane progesterone receptor expression in mammalian tissues: a review of regulation and physiological implications","volume":"76","author":"Dressing","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0320","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1128\/MCB.25.12.4826-4840.2005","article-title":"Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells","volume":"25","author":"Proietti","year":"2005","journal-title":"Mol.Cell Biol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0325","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.steroids.2010.12.008","article-title":"Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer","volume":"76","author":"Proietti","year":"2011","journal-title":"Steroids."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0330","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/09513599909167574","article-title":"The pharmacological profile of a novel norpregnance progestin (trimegestone)","volume":"13","author":"Philibert","year":"1999","journal-title":"Gynecol. Endocrinol."},{"issue":"Suppl. 1","key":"10.1016\/j.jsbmb.2019.105548_bib0335","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0340","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jsbmb.2013.08.001","article-title":"Potency of progestogens used in hormonal therapy: toward understanding differential actions","volume":"142","author":"Hapgood","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0345","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-13-0742","article-title":"Reprogramming the chromatin landscape: interplay of the estrogen and glucocorticoid receptors at the genomic level","volume":"73","author":"Miranda","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0350","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cell.2016.02.067","article-title":"Steroid receptors reprogram FoxA1 occupancy through dynamic chromatin transitions","volume":"165","author":"Swinstead","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0355","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1210\/me.2011-1314","article-title":"Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor alpha in luminal breast cancer cells","volume":"26","author":"Need","year":"2012","journal-title":"Mol.Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0360","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.cell.2011.07.006","article-title":"Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism","volume":"146","author":"Voss","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0365","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2019.105548_bib0370","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/ng.759","article-title":"Chromatin accessibility pre-determines glucocorticoid receptor binding patterns","volume":"43","author":"John","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0375","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1038\/emboj.2011.328","article-title":"Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer","volume":"30","author":"Sahu","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0380","doi-asserted-by":"crossref","first-page":"4230","DOI":"10.1093\/nar\/gkt1401","article-title":"Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo","volume":"42","author":"Sahu","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0385","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-12-2350","article-title":"FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells","volume":"73","author":"Sahu","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2019.105548_bib0390","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molcel.2012.10.019","article-title":"Nucleosome-driven transcription factor binding and gene regulation","volume":"49","author":"Ballare","year":"2013","journal-title":"Mol. Cell"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019302766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076019302766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:04:20Z","timestamp":1760745860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076019302766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":78,"alternative-id":["S0960076019302766"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105548","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105548"}}